- Home
- MREO vs NWPX Comparison
MREO vs NWPX Comparison
Compare MREO & NWPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- NWPX
- Stock Information
- Founded
- MREO 2015
- NWPX 1966
- Country
- MREO United Kingdom
- NWPX United States
- Employees
- MREO N/A
- NWPX N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- NWPX Steel/Iron Ore
- Sector
- MREO Health Care
- NWPX Industrials
- Exchange
- MREO Nasdaq
- NWPX Nasdaq
- Market Cap
- MREO 369.2M
- NWPX N/A
- IPO Year
- MREO N/A
- NWPX 1995
- Fundamental
- Price
- MREO $2.42
- NWPX $38.56
- Analyst Decision
- MREO Strong Buy
- NWPX Hold
- Analyst Count
- MREO 7
- NWPX 1
- Target Price
- MREO $7.71
- NWPX $55.00
- AVG Volume (30 Days)
- MREO 1.5M
- NWPX 56.0K
- Earning Date
- MREO 05-19-2025
- NWPX 04-30-2025
- Dividend Yield
- MREO N/A
- NWPX N/A
- EPS Growth
- MREO N/A
- NWPX 37.25
- EPS
- MREO N/A
- NWPX 3.27
- Revenue
- MREO N/A
- NWPX $495,448,000.00
- Revenue This Year
- MREO N/A
- NWPX $2.48
- Revenue Next Year
- MREO $56.11
- NWPX $4.49
- P/E Ratio
- MREO N/A
- NWPX $11.40
- Revenue Growth
- MREO N/A
- NWPX 8.06
- 52 Week Low
- MREO $1.58
- NWPX $32.04
- 52 Week High
- MREO $5.02
- NWPX $57.76
- Technical
- Relative Strength Index (RSI)
- MREO 50.79
- NWPX 39.53
- Support Level
- MREO $2.28
- NWPX $36.97
- Resistance Level
- MREO $2.75
- NWPX $42.88
- Average True Range (ATR)
- MREO 0.16
- NWPX 1.42
- MACD
- MREO 0.00
- NWPX -0.34
- Stochastic Oscillator
- MREO 32.65
- NWPX 25.08
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).